Management of Pediatric Brain Tumors with the Aid of PET/MR Imaging.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
The review highlights clinical use cases of PET/MR imaging in a pediatric multispecialty neuro-oncology practice with a focus on the role of hybrid imaging with PET/MR imaging, the application of the clinically available tracer fluorodeoxyglucose (18F-FDG), and opportunities in the implementation of amino acid-based tracers. Clinical examples of 18F-FDG hybrid PET/MR imaging use in pediatric diffuse gliomas, medulloblastomas, atypical teratoid rhabdoid tumor, metastatic disease with spine involvement, and cases where a brain tumor presents as a second malignancy are highlighted.